Results 281 to 290 of about 249,445 (302)

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

Clinical Microbiology and Infection, 2022
Paul Loubet, Simon Galmiche, Liem Binh Luong Nguyen   +2 more
exaly  

Immunocompromised children with cancer.

Rays, 1994
no
Mastrangelo R., Tornesello A., Mastrangelo S., Riccardi R.   +3 more
openaire   +2 more sources

Norovirus in Immunocompromised Patients

Oncology Nursing Forum, 2013
Jill, Atmar, Ellen, Mullen
openaire   +2 more sources

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Cell, 2020
Craig Martens, Rhys Pryce, Kent D Barbian   +2 more
exaly  

Lymphoma and the Immunocompromised Host

New England Journal of Medicine, 1979
A H, Filipovich, B D, Spector, G, Frizzera, J H, Kersey   +3 more
openaire   +2 more sources

Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial

Infection, 2023
Ilseyar Khaertynova, Amanda Paschke, Pierre Delobel   +2 more
exaly  

Coronavirus Disease-2019 in the Immunocompromised Host

Clinics in Chest Medicine, 2023
Ajay Sheshadri
exaly  

Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients

Clinical Microbiology and Infection, 2022
Guillemain Romain, Marguerite Vignon, Véronique Boussaud   +2 more
exaly  

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

Clinical Infectious Diseases, 2014
Lillian Sung, E Graham Davies
exaly  

Herpes zoster and the immunocompromised

Journal of Infection, 1987
openaire   +2 more sources